Nam-Seok Joo, et al. and Nutrition Examination Survey II Mortality Study. Atheroscle- rosis 2004;173:309-14. 9. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all- cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76. 10. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res 2001;9:210-8. 11. Tamura T, Ohmori K. Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. Eur J Pharmacol 2001;419:269-74. 12. Tamura T, Shirai T, Kosaka N, Ohmori K, Takafumi N. Pharma- cological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur J Pharmacol 2002;448:81-7. 13. Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum 2000;43:2339-48. 14. Nguyen M, Dougados M, Berdah L, Amor B. Diacerein in the treatment of osteoarthritis of the hip. Arthritis Rheum 1994;37: 529-36. 15. Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 2002;106:679-84. 16. Mohanty P, Aljada AS, Ghanim H, Hofmeyer D, Tripathy D, Syed T, et al. Evidence for a potent antiinflammatory effect of rosigli- tazone. J Clin Endocrinol Metab 2004;89:2728-35. 17. Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, et al. Differential effects of metformin and troglitazone on cardiovas- cular risk factors in patients with type 2 diabetes. Diabetes Care 2002;25:542-9. 18. Kasim-Karakas SE, Tsodikov A, Singh U, Jialal I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 2006;83:774-9. 19. Seshadri P, Iqbal N, Stern L, Williams M, Chicano KL, Daily DA, et al. A randomized study comparing the effects of a low-carbohy- drate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am J Med 2004;117:398-405. 20. Manigrasso MR, Ferroni P, Santilli F, Taraborelli T, Guagnano MT, Michetti N, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005;90:5876-9. 21. Caballero AE, Delgado A, Aguilar-Salinas CA, Herrera AN, Cas- tillo JL, Cabrera T, et al. The differential effects of metformin on markers of endothelail activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled randomized clinical trial. J Clin Endocrinol Metab 2004;89:3943-8. 22. Nicklas BJ, Ambrosius W, Messier SP, Miller GD, Penninx BW, Loeser RF, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clini- cal trial. Am J Clin Nutr 2004;79:544-51. 23. Risérus U, Vessby B, Arnlöv J, Basu S. Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004;80:279-83. 24. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-804. 25. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9. 26. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive pro- tein and other markers of inflammation in the prediction of cardio- vascular disease in women. N Engl J Med 2000;342:836-43. 27. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma con- centrations of interleukin-6 and the risk of future myocardial in- farction among apparently healthy men. Circulation 2000;101: 1767-72. 28. Stefan N, Stumvoll M. Adiponectin--its role in metabolism and beyond. Horm Metab Res 2002;34:469-74. 248 Yonsei Med J http://www.eymj.org Volume 52 Number 2 March 2011